SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-006465
Filing Date
2021-03-19
Accepted
2021-03-19 17:30:01
Documents
99
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1371546
2 ex4-11.htm EX-4.11 5892
3 ex10-44.htm EX-10.44 328267
4 ex21.htm EX-21 4254
5 ex23-1.htm EX-23.1 3333
6 ex31.htm EX-31 37445
7 ex32.htm EX-32 8604
8 form10-k_001.jpg GRAPHIC 83817
9 form10-k_002.jpg GRAPHIC 82700
10 form10-k_003.jpg GRAPHIC 77133
11 form10-k_004.jpg GRAPHIC 35615
  Complete submission text file 0001493152-21-006465.txt   7701847

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE ocx-20201231.xml EX-101.INS 1086226
13 XBRL SCHEMA FILE ocx-20201231.xsd EX-101.SCH 83930
14 XBRL CALCULATION FILE ocx-20201231_cal.xml EX-101.CAL 107521
15 XBRL DEFINITION FILE ocx-20201231_def.xml EX-101.DEF 321203
16 XBRL LABEL FILE ocx-20201231_lab.xml EX-101.LAB 578647
17 XBRL PRESENTATION FILE ocx-20201231_pre.xml EX-101.PRE 467125
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37648 | Film No.: 21759224
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences